Hereditary Angioedema Clinical Trials

A listing of Hereditary Angioedema medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 23 clinical trials
featured
Hereditary Angioedema (HAE)

An open-label study to evaluate the long-term safety of daily oral BCX7353 in subjects with Type I and Type II hereditary angioedema.

angioedema
  • 22 views
  • 14 May, 2020
  • 1 location
featured
HAE - Patients diagnosed with Acute Hereditary Angioedema

HAE - Patients diagnosed with Acute Hereditary Angioedema

  • 598 views
  • 08 Nov, 2020
  • 1 location
CSL312 (Garadacimab) in the Prevention of Hereditary Angioedema Attacks

prophylactic treatment of hereditary angioedema

angioedema
  • 0 views
  • 01 Jul, 2021
  • 22 locations
Long-term Safety and Efficacy of CSL312 (Garadacimab) in the Prophylactic Treatment of Hereditary Angioedema Attacks

This phase 3b study will evaluate long-term safety and efficacy of CSL312 (also known as garadacimab) when administered subcutaneously (SC)

angioedema
  • 0 views
  • 27 Jul, 2021
  • 11 locations
Efficacy and Safety of Lanadelumab (SHP643) in Japanese Participants With Hereditary Angioedema (HAE)

The purpose of this phase 3, open-label, multi-center study is to evaluate the safety and efficacy of lanadelumab in Japanese participants with HAE Type I or II.

c1 inhibitor (human)
angioedema
bilateral oophorectomy
  • 5 views
  • 23 Mar, 2021
  • 12 locations
Expanded Access Program With Lanadelumab for Japanese People With Hereditary Angioedema

angioedema attacks. Lanadelumab is not yet licensed for use in Japan. The main aim of this study is to allow Japanese teenagers and adults with type I or type II hereditary angioedema to be treated

angioedema
bilateral oophorectomy
  • 0 views
  • 19 Jul, 2021
  • 10 locations
Lanadelumab in FXII-associated Cold Autoinflammatory Syndrome (FACAS)

This is a Phase 2, exploratory, proof-of-concept, single-center, open-label pilot study to assess the effects and safety of Lanadelumab in patients with FXII-associated cold autoinflammatory syndrome (FACAS).

  • 0 views
  • 26 Jan, 2021
  • 1 location
Dose-ranging Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema

This study evaluates the efficacy of orally administered PHA-022121 for the acute treatment of attacks in patients with hereditary angioedema (HAE). Eligible subjects are randomized to one of

angioedema
  • 0 views
  • 24 Jul, 2021
  • 22 locations
Contrast-Enhanced Ultrasound for the Evaluation of Changes in Tumor Blood Flow Surrounding HAE

The purpose of the study is to find out if a study agent called Lumason microbubbles may be helpful for people with lesions in the liver. It is possible it may help determine an early response to radioembolization and/or help demonstrate radiation toxicity to the surrounding liver.

serum bilirubin
tumor burden
radioembolization
measurable disease
hepatocellular carcinoma
  • 0 views
  • 22 Jul, 2021
  • 1 location
The Role of the Coagulation Pathways in Recurrent Angioedema

Previous studies reported infraclinical modifications of the homeostasis in chronic urticaria, recurrent idiopathic angioedema and hereditary angioedema. This study aim to compare groups with

  • 60 views
  • 17 Mar, 2021
  • 1 location